Rosuvastatin: A new HMG-CoA reductase inhibitor for the treatment of dyslipidemia

dc.contributor.authorLenz, T. L.en_US
dc.contributor.authorFaulkner, M. A.en_US
dc.contributor.authorRyan-Haddad, A.en_US
dc.contributor.cuauthorFaulkner, Michele A.en_US
dc.contributor.cuauthorLenz, Thomas L.en_US
dc.contributor.cuauthorRyan-Haddad, Ann M.en_US
dc.date.accessioned2015-03-27T20:24:14Z
dc.date.available2015-03-27T20:24:14Z
dc.date.issued2004en_US
dc.date.monthSpringen_US
dc.date.year2004en_US
dc.description.pages136-145en_US
dc.description.volume2en_US
dc.identifier.citationLenz, TL; Faulkner, MA; Ryan-Haddad, A. Rosuvastatin: A new HMG-CoA reductase inhibitor for the treatment of dyslipidemia. Advances in Pharmacy. 2004, SPR. 2:136-145.en_US
dc.identifier.issn1532-3862en_US
dc.identifier.issn1532-3862en_US
dc.identifier.urihttp://hdl.handle.net/10504/67844
dc.program.unitSchool of Pharmacy and Health Professionsen_US
dc.titleRosuvastatin: A new HMG-CoA reductase inhibitor for the treatment of dyslipidemiaen_US
dc.title.workAdvances in Pharmacyen_US
dc.typeJournal Articleen_US
dc.url.link1http://cuhsl.creighton.edu/login?url=http://kc7za5wx4c.search.serialssolutions.com/?sid=Refworks&charset=utf-8&__char_set=utf8&genre=article&aulast=Lenz&auinit=T.&title=Advances%20in%20Pharmacy&date=2004&volume=2&pages=136-145&issn=15323862&atitle=Rosuvastatin%3A%20A%20new%20HMG-CoA%20reductase%20inhibitor%20for%20the%20treatment%20of%20dyslipidemia&spage=136&au=Lenz%2CTL&au=Faulkner%2CMA&au=Ryan-Haddad%2CA.&en_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: